Critical questions concerning the validity of the Bayer study report of "Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration".
Meyer
M C
MC
D001682:Biological Availability; D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002170:Canada; D018849:Controlled Clinical Trials as Topic / Q000592:standards*; D003692:Delayed-Action Preparations; D017408:Guidelines as Topic; D006801:Humans; D009543:Nifedipine / Q000008:administration & dosage* / Q000493:pharmacokinetics; D009995:Osmosis; D012107:Research Design / Q000592:standards; D013607:Tablets; D013810:Therapeutic Equivalency
D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D013607:Tablets; D009543:Nifedipine